Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

By Catalona W.J.   Partin A.W.   Finlay J.A.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Clinical significance of small (less than 0.2 cm 3 ) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mL - value of the ''seventh biopsy'' targeted to visible lesions

By Fleshner N.E.   O'Sullivan M.   Premdass C.   Fair W.R.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 356-358

Elsevier

Access to resources Recommend Favorite

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL

By Eastham J.A.   May R.   Robertson J.L.   Sartor O.   Kattan M.W.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 709-713

Elsevier

Access to resources Recommend Favorite

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL - Part 1: results of a retrospective evaluation of 1726 men

By Tornblom M.   Norming U.   Adolfsson J.   Becker C.   Abrahamsson P.-A.   Lilja H.   Gustafsson O.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 945-950

Elsevier

Access to resources Recommend Favorite

The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4–10 ng/mL

By Ng C.   Chiu Peter   Lam N.   Lam H.   Lee Kim   Hou Simon  

International Urology and Nephrology, Vol. 46, Iss. 4, 2014-04 ,pp. : 711-717

Springer Publishing Company

Access to resources Recommend Favorite